In 2021, 30 EU/EEA countries reported 3 864 cases of hepatitis A (Table 1). The EU/EEA notification rate was 0.9 cases per 100 000 population. In 2021, both the lowest number of reported cases and the lowest notification rate were reported since the beginning of EU-level hepatitis A surveillance in 2007. The total number of hepatitis A cases reported in EU/EEA countries in 2021 represented a decrease of 65.7% and 12.3% compared to 2019 and 2020, respectively.
This issue of the CDTR covers the period 11 – 17 December 2022 and includes updates on COVID-19, diphtheria, measles, streptococcal infection, invasive meningococcal disease, poliomyelitis, influenza, mass gathering monitoring, and Ebola virus disease.
A number of European countries (including Ireland, France, the Netherlands, Sweden and the United Kingdom) indicate an increase seen during 2022, particularly since September 2022, in the number of cases of invasive Group A Streptococcus (iGAS) disease among children less than ten years of age.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.
More than 35 000 people die from antimicrobial-resistant infections in the EU/EEA each year, according to estimates presented in a new report released today. The estimated number of deaths in the report examines the years 2016-2020 and shows an increase from previous estimates. The health impact of antimicrobial resistance (AMR) is comparable to that of influenza, tuberculosis and HIV/AIDS combined.